Investment analysts at StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a note issued to investors on Wednesday. The brokerage set a “sell” rating on the stock.
Ampio Pharmaceuticals Stock Performance
Ampio Pharmaceuticals stock opened at $0.00 on Wednesday. The stock has a 50-day moving average of $0.01 and a two-hundred day moving average of $0.01. Ampio Pharmaceuticals has a one year low of $0.00 and a one year high of $2.47. The stock has a market cap of $2,394.00, a PE ratio of 0.00 and a beta of 3.66.
Ampio Pharmaceuticals Company Profile
Read More
- Five stocks we like better than Ampio Pharmaceuticals
- Stock Market Sectors: What Are They and How Many Are There?
- Hims & Hers Earnings Could Be a Game Changer—What to Do Now
- Election Stocks: How Elections Affect the Stock Market
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- Market Cap Calculator: How to Calculate Market Cap
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
